On July 14, 2025, NKGen Biotech, Inc. entered into a stock purchase agreement with HekaBio K.K. to sell 8,000,000 shares of common stock at $0.25 per share for a total of $2 million. Additionally, the company's stock will transition to the Expert Market due to missed filing requirements.